Efficacy of a multi-component exercise programme and nutritional supplementation on musculoskeletal health in men treated with androgen deprivation therapy for prostate cancer (IMPACT): study protocol of a randomised controlled trial

[1] Torre LA(2015)Global cancer statistics, 2012 CA Cancer J Clin 65 87-108

[2] Bray F(2014)Cancer treatment and survivorship statistics, 2014 CA Cancer J Clin 64 252-271

[3] Siegel RL(2002)Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial Lancet 360 103-108

[4] Ferlay J(2005)Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: results from the Trans-Tasman Radiation Oncology Group 96.01 randomised controlled trial Lancet Oncol 6 841-850

[5] Lortet-Tieulent J(2006)Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy Lancet Oncol 7 472-479

[6] Jemal A(2005)Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma: long-term results of phase III RTOG 85–31 Int J Radiat Oncol Biol Phys 61 1285-1290

[7] DeSantis CE(2004)6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial JAMA 292 821-827

[8] Lin CC(2008)Survival following primary androgen deprivation therapy among men with localized prostate cancer JAMA 300 173-181

[9] Mariotto AB(2005)Increasing use of gonadotropin-releasing hormone agonists for the treatment of localized prostate carcinoma Cancer 103 1615-1624

[10] Siegel RL(2011)Bone and metabolic health in patients with non-metastatic prostate cancer who are receiving androgen deprivation therapy Med J Aust 194 301-306

[1] Torre LA(2015)Global cancer statistics, 2012 CA Cancer J Clin 65 87-108

[2] Bray F(2014)Cancer treatment and survivorship statistics, 2014 CA Cancer J Clin 64 252-271

[3] Siegel RL(2002)Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial Lancet 360 103-108

[4] Ferlay J(2005)Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: results from the Trans-Tasman Radiation Oncology Group 96.01 randomised controlled trial Lancet Oncol 6 841-850

[5] Lortet-Tieulent J(2006)Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy Lancet Oncol 7 472-479

[6] Jemal A(2005)Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma: long-term results of phase III RTOG 85–31 Int J Radiat Oncol Biol Phys 61 1285-1290

[7] DeSantis CE(2004)6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial JAMA 292 821-827

[8] Lin CC(2008)Survival following primary androgen deprivation therapy among men with localized prostate cancer JAMA 300 173-181

[9] Mariotto AB(2005)Increasing use of gonadotropin-releasing hormone agonists for the treatment of localized prostate carcinoma Cancer 103 1615-1624

[10] Siegel RL(2011)Bone and metabolic health in patients with non-metastatic prostate cancer who are receiving androgen deprivation therapy Med J Aust 194 301-306